Ben Shamsian
Investor Relations, Lithlum Partners
Replay available
Biofrontera Inc. (NASDAQ: BFRI) Q3 2025 earnings conference call, held 2025-11-13. Replay captured from the company's public earnings webcast.

Investor Relations, Lithlum Partners
CEO, Chairman and Founder of BioFrontera
Analyst, The Benchmark Company
CFO, BioFrontera Inc.
Welcome to the BioFrontera Inc. Third Quarter 2025 Financial Results and Business Update Conference Call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. Please note, this event is being recorded. I would now like to turn the conference over to Ben Shamsian with Lithlum Partners Investor Relations. Please go ahead. Thank you. Good morning and welcome to Biofrantera Inc's third quarter fiscal year 2025 financial results and business update conference call. Please note that certain information discussed during today's call by management is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that Biofrantera's management will be making forward-looking statements and that actual results may differ materially from those stated or implied by these forward-looking statements, the risks and uncertainties associated with the company's business. All risks and uncertainties are detailed and are qualified by the cautionary statements contained in BioFrontera's press releases and SEC filings. Also, this conference call contains time-sensitive information, that is accurate only as of the date of the live broadcast, November 13, 2025. BioFrontera undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of the conference call, except as required by law. During today's call, there will be references to certain non-GAAP financial measures. BioFrontera believes these measures provide useful information for investors, yet should not be considered as a substitute for GAAP, nor shou...